Journals / GORM:Gynecology Obstetrics & Reproductive Medicine / 2008 / Cilt: 14 - Sayı: 1

Bir grup gebede parvovirüs enfeksiyonu ve seropozitivitesi

Parvovirus infection and seropositivity in a group of pregnant women

Pages
12–15
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In our opinion, routine screening of parvovirus B 19 infection should not recommended during pregnancy and screening should be limited with the hydropic fetuses because of some reasons including rarity of acute maternal infection during pregnancy, difficulty in predicting of foetal transmission, and irrelevance with fetal anomalies, rarity of miscarriage and hydrops foetalis even if fetal infection is considered.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVE: Detection of parvovirus B19 seropositivity in a group of pregnant women.
📊
Key Findings & Data:STUDY DESIGN: Parvovirus B19 IgM and IgG seropositivity was investigated in 58 pregnant women.
💡
Conclusion & Impact:In our opinion, routine screening of parvovirus B 19 infection should not recommended during pregnancy and screening should be limited with the hydropic fetuses because of some reasons including rarity of acute maternal infection during pregnancy, difficulty in predicting of foetal transmission, and irrelevance with fetal anomalies, rarity of miscarriage and hydrops foetalis even if fetal infection is considered.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

OBJECTIVE: Detection of parvovirus B19 seropositivity in a group of pregnant women. STUDY DESIGN: Parvovirus B19 IgM and IgG seropositivity was investigated in 58 pregnant women. RESULTS: None of the 58 pregnant women had parvovirus B19 IgM seropositivity and 27% (n: 16) of the patients had IgG seropositivity. CONLUSIONS: Parvovirus B19 IgG seropositivity increases in pregnants by aging and it is reported as 60- 70 %. In our study the seropositivity was lower than the rates reported in the literature. Parvovirus B 19 infection is rare during pregnancy. Maternal- to- foetal transmission during acute maternal infection is about 33 %. Most of the foetal infections are asymptomatic. Common clinic presentations are miscarriage or foetal non-immun hydrops. In our opinion, routine screening of parvovirus B 19 infection should not recommended during pregnancy and screening should be limited with the hydropic fetuses because of some reasons including rarity of acute maternal infection during pregnancy, difficulty in predicting of foetal transmission, and irrelevance with fetal anomalies, rarity of miscarriage and hydrops foetalis even if fetal infection is considered.

Özet

Bir grup gebede parvovirus B 19 seropozitivitesinin saptanması. Elli sekiz gebede parvovirus B 19 IgM ve IgG seropozitivitesi araştırıldı. Elli sekiz gebenin hiçbirinde IgM seropozitivitesi saptanmadı ve % 27'sinde (n- 16) IgG seropozitivitesi saptandı. Parvovirus B 19 IgG seropozitivitesi gebelerde yaşla birlikte artar ve yaklaşık % 60- 70 oranında bildirilmektedir. Bizim çalışmamızda seropozitivite oranı literatürde bildirilenden daha düşüktür. Gebelik esnasında parvovirus B19 infeksiyonu nadirdir. Akut maternal infeksiyon esnasında anneden fetusa geçiş % 33' tür. Fetal infeksiyonların çoğu asemptomatikdir. En sık karşılaşılan klinik durumlar düşük ve fetal non-hidrops fetalis-tir. Gebelik esnasında parvovirus B19 enfeksiyonunun rutin taramasını önermemekteyiz ve akut maternal enfeksiyonun seyrek görülmesi, fetal geçişin önceden gösterilememesi ve fetal enfeksiyon oluşsa bile fetal anomali yapmaması, düşük ve hidropsun ender görülmesi nedeniyle tarama sadece hidropik fetuslarla sınırlandırılmalıdır.

🔖

Cite This Article

COŞKUN, A., KIRAN, G., GÜVEN, A. M., ÖZDEMİR, Ö., KÖSTÜ, B., Aral, M. (2008). Bir grup gebede parvovirüs enfeksiyonu ve seropozitivitesi. GORM:Gynecology Obstetrics & Reproductive Medicine, Cilt: 14 - Sayı: 1, 12–15. https://ajindex.com/articles/227056

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Alanen A, Kahala K, Vahlberg T, Koskela P, Vainionpaa R. Seroprevalence, incidence of prenatal infections and reliability of maternal history of varicella zoster virus, cy-tomegalovirus, herpes simplex virus and parvovirus B19 infection in South-Western Finland. BJOG 2005;l 12:50-6. 2.McCarter-Spaulding D. Parvovirus B19 in pregnancy. J Obstet Gynecol Neonatal Nurs 2002; 31:107-12. 3.Sodja I, Mrazova M, Smelhausova M, Uhlir M, Kotrbova K, Pazdiora P, Braj J, Kadlecik D. Parvovirus B 19 in pregnancy. Epidemiol Mikrobiol Imunol 1996; 45: 143-7. 4.Markenson GR, Yancey MK. Parvovirus B19 infections in pregnancy. Semin Perinatol 1998; 22:309-17. 5.Enders M, Weidner A, Zoellner I, Searle K, Enders G. Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases. Prenat Diagn 2004; 24:513-8. 6.No authors listed. Leads from the MMWR. Risks associated with human parvovirus B19 infection. JAMA 1989; 261:1406-8. 7.Devine PA. Parvovirus infection in women. Prim Care Update Obstet Gynecol 2002;9:149-53. 8.Valeur-Jensen AK, Pedersen CB, Westergaard T, Jensen IP, Lebech M, Andersen PK et al. Risk factors for parvovirus B19 infection in pregnancy. JAMA.1999;281: 1099-105. 9.Jensen IP, Thorsen P, Jeune B, Moller BR, Vestergaard BE. An epidemic of parvovirus B19 in a population of 3596 pregnant women: a study of sociodemographic and medical risk factors. British Journal of Obstetrics and Gynaecology 2000;107:637-643. 10.Carter-Spaulding D. Parvovirus B19 in pregnancy. J Obstet Gynecol Neonatal Nurs 2002; 31:107-12. 11.Gratacös E, Torres PJ, Vidal J, Antolin E, Costa J, Jimenez de Anta MT et al. The incidence of human parvovirus B19 infection during pregnancy and its impact on perinatal outcome. J Infecr Dis 1995; 171:1360-3. 12.Yaegashi N, Niinuma T, Chisaka H et al. Serologic study human parvovirus B19 infection in pregnancy in Japan. J Infecr Dis 1999; 38:30-5. 13.Maksheed M, Pacsa AS, Essa SS, Ahmed MA, Monem RA, Surkouh M. The prevalence of antibody to human parvovirus B19 in pregnant women in Kuwait. Açta Trop 1999; 73:225-9. 14.Enders G, Biber M. Parvovirus B19 infections in pregnancy. Behring Inst Mitt 1990; 85: 74-8. 15.Skjoldebrand-Sparre L, Fridell E, Nyman M, Wahren B. A prospective study of antibodies against parvo virus B19 in pregnancy. Acta Obstet Gynecol Scand 1996; 75: 336-9. 16.Cline MK, Bailey-Dorton C, Cayelli M. Maternal infections: diagnosis and management. Prim Care. 2000; 27: 13-33. 17.E